# FDA Inspection 827247 - Jubilant DraxImage Inc., dba Jubilant Radiopharma - April 12, 2013

Source: https://www.keypedia.com/records/fda_inspections/jubilant-draximage-inc-dba-jubilant-radiopharma/08330115-3fbd-4b5d-b366-883af9c72cc9
Source feed: FDA_Inspections

> FDA Inspection 827247 for Jubilant DraxImage Inc., dba Jubilant Radiopharma on April 12, 2013. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 827247
- Company Name: Jubilant DraxImage Inc., dba Jubilant Radiopharma
- Inspection Date: 2013-04-12
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1308792 - 2026-03-23](https://www.keypedia.com/records/fda_inspections/jubilant-draximage-inc-dba-jubilant-radiopharma/30cde839-f0c5-4e2e-8665-b804efa6e542)
- [FDA Inspection 984555 - 2016-09-13](https://www.keypedia.com/records/fda_inspections/jubilant-draximage-inc-dba-jubilant-radiopharma/1e489d0a-b5b9-44df-a2f4-657425e8570b)

Company: https://www.keypedia.com/companies/jubilant-draximage-inc-dba-jubilant-radiopharma/e93ebd53-d49f-4ec4-8e7f-e24361a47374

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c